Published in
Elsevier, Leukemia Research, (74), p. 89-96, 2018
DOI: 10.1016/j.leukres.2018.10.002
Links
Tools
A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease
Journal article published in 2018 by
Kendra Sweet,
Lori Hazlehurst,
Eva Sahakian,
John Powers 
,
Lisa Nodzon,
Fadi Kayali,
Kelly Hyland,
Ashley Nelson,
Javier Pinilla-Ibarz
,
Lisa Nodzon,
Fadi Kayali,
Kelly Hyland,
Ashley Nelson,
Javier Pinilla-Ibarz
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 